Background : Dysmenorrhea is the most common gynecologic complaint among adolescent females. We investigated the association between genetic polymorphisms and dysmenorrhea.
INTRODUCTION
Dysmenorrhea is the most common gynecologic complaint among adolescent females and it is characterized by symptoms ranging from lower abdominal cramping and back pain to nausea, vomiting, and diarrhea. Dysmenorrhea is categorized as primary (in the absence of organic pelvic pathology) or secondary (in the presence of organic diseases such as endometriosis and adhesive disease). It is prevalent in 60-93% female adolescents [1, 2] . Pelvic abnormalities, such as endometriosis or uterine anomalies, are identified only in approximately 10% of female adolescents with severe dysmenorrheal symptoms [3] .
The cause of dysmenorrhea is not completely understood, but its major biological pathways are believed to involve endocrine, myometrial, and prostaglandin factors [2] . A variety of gene polymorphisms have been investigated, but only a few have shown an association with dysmenorrhea. Epidemiologic studies have shown a link between dysmenorrhea and several environmental factors, including smoking and alcohol intake [4, 5] . It is thought that an association exists between the detoxification activi-
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Estrogen receptor 1, Glutathione S-transferase P1, Glutathione S-transferase M1, and Glutathione S-transferase T1 Genes with Dysmenorrhea in Korean Female Adolescents ty of endogenous or exogenous substances and adverse reproductive outcomes [6] . Several studies have shown the relationship between the risk of dysmenorrhea and metabolic gene polymorphisms, such as the glutathione S-transferase (GST)-related genes or cytochrome P450
genes that are associated with the detoxification process [7, 8] . However, other studies have reported no significant association between GST-related genes and dysmenorrhea [9, 10] . Dysmenorrhea does not occur during anovulatory cycles but occurs in the process of ovulation, and the effects of progesterone and estrogen on the endometrium and myometrium appear to constitute a primary mechanism. In the uterus, a strong estrogen receptor 1 (ESR1) immunoreactivity has been detected in the nuclei of epithelial, stromal, and muscle cells [11] . Endometriosis, the most common secondary dysmenorrhea, is considered an estrogen-dependent disorder, and although its association with ESR1 gene polymorphisms has been discussed, it remains controversial [12, 13] . Three polymorphisms in the ESR1 gene, i.e., intron 1 polymorphisms involving PvuII and XbaI and (TA)n repeat allelic variants in the 5-prime upstream of exon 1, have mainly been investigated. The ESR1 PvuII polymorphism has been analyzed and reported most frequently, and the PvuII polymorphic site is known to abolish an activator-protein 4
(AP-4) transcription factor binding site, as determined by homology with the DNA consensus sequence [14] . A polymorphism in a protein-coding region, G229A in exon 1 of the ESR1 gene, has also been analyzed, but no relationship between this polymorphism and dysmenorrhea was observed [13] .
Investigating the relationship between genetic polymorphisms and dysmenorrhea will be helpful in elucidating the pathophysiology of dysmenorrhea and in finding solutions to provide clinical care for adolescents with dysmenorrhea. However, no study has addressed the association between genetic polymorphisms and dysmenorrhea in a homogenous adolescent population. In this study, we investigated the association between GST mu 1 (GSTM1), GST theta 1 (GSTT1), GST pi 1 (GSTP1), and ESR1 gene polymorphisms and dysmenorrhea in Korean female adolescents.
MATERIALS AND METHODS

Subjects
We recruited 333 postmenarcheal Korean female adolescents aged 16-17 yr from 2 all-girls high schools in Seoul, South Korea, and 205 (61.6%) girls participated in this study. We obtained informed consent from all subjects and their parents. Participants who had undergone surgery, chemotherapy, radiation therapy, or treatment for obstetric/gynecologic diseases, and had been pregnant or were consuming exogenous hormones during the preceding 3 months were excluded from the study population.
We also excluded participants who were suspected of hav- 
Menstrual data
We obtained menstrual data, including age at menarche, menstrual cycle regularity, duration of menstrual bleeding, amount of menstrual bleeding, dysmenorrhea, premenstrual syndrome (PMS), and first-degree family history of dysmenorrhea. Dysmenorrhea was defined as pelvic or lower abdominal pain associated with menstruation during every period.
DNA extraction
Peripheral blood was drawn from each subject and collected in a tube in which ethylenediaminetetraacetic acid (EDTA) was added. Genomic DNA was extracted from leukocytes using the QIAamp blood kit (Qiagen, Hilden, Germany) according to the instructions of the manufacturer.
Genotyping
1) ESR1 genotyping
Genotyping of the PvuII polymorphism in intron 1, which is 0.4 kb upstream of exon 2 of the ESR1 gene (rs2234693), was determined by PCR-restriction fragment length polymorphism (RFLP) analysis, essentially as described previously [16] . The sequences of the primers are listed in Table 1 . Genotypes were defined as PP, Pp, and pp. Uppercase letters represent the absence of restriction sites, and lower-case letters represent the presence of restriction sites.
2) GSTM1 and GSTT1 genotyping GSTM1 and GSTT1 genotyping for gene deletions were carried out by PCR as described by Lin et al. [17] with minor modifications. The sequences of the primers are listed in Table 1 . Amplification of the beta-actin gene was used as an internal control. If the study subject was null for the gene, no PCR product was present.
3) GSTP1 genotyping
An A to G transition in codon 105 (exon 5) of the GSTP1 gene (rs1695) resulting in an Ile to Val amino acid substitution was determined by PCR-RFLP according to the method of Harris et al. [18] . The sequences of the primers are listed in Table 1 
Statistical analysis
This study was designed to have 80% power at the 5% significance level to detect the odds ratio (OR) of 2.0, assuming that risk genotype rate is 60% [19] and the prevalence of the dysmenorrhea genotype is 75% in general adolescent population [20] .
Statistical significance of differences between groups was determined using the Fisher' s exact test. Using a 95%
confidence interval (CI), we first estimated the ORs for the association of genetic polymorphisms with the risk of dysmenorrhea using a univariate logistic regression analysis. We then developed a second model adjusting for variables that might confound the relationship between genetic polymorphisms and dysmenorrhea and calculated adjusted ORs. We adjusted for the variables, which showed significant associations with dysmenorrhea using Fisher' s exact tests.
The presence of Hardy-Weinberg equilibrium for genotype frequencies was calculated using the Chi-square ( c 2 ) test. All of the analyses were performed using SPSS statistical software (SPSS, Inc., Chicago, IL, USA), with the cutoff point for statistical significance set at P<0.05.
RESULTS
The baseline characteristics of the subjects enrolled in this study are shown in Table 2 . The mean age at menarche was 13.4 yr (range, 11-16 yr). Among 202 girls, 172
GSTP1
(F) 5′ -ACCCCAGGGCTCTATGGGAA-3′ 176 (R) 5′ -TGAGGGCACAAGAAGCCCCT-3′ Table 1 . Primer sequences for PCR in this study girls (85.1%) had dysmenorrhea during every period. The statistical power of the analysis, which was calculated from the prevalence of dysmenorrhea seen in this study, was 57% at the 5% significance level.
We analyzed the association between BMI, menstrual factors, first-degree family history of dysmenorrhea, smoking, and alcohol intake and dysmenorrhea. In a two-bytwo c 2 analysis, presence of PMS (P=0.000), an early age at menarche (P=0.005), and a first-degree family history (P=0.000) were significantly related to an increased risk of dysmenorrhea (a portion of this menstrual data was previously published in a local Korean journal) [21] . gene polymorphisms remained significant after adjustment for PMS, years elapsed after menarche, and family history of dysmenorrhea, which showed significant associations with dysmenorrhea using Fisher' s exact tests. No significant difference was observed between subjects with dysmenorrhea and subjects without dysmenorrhea for the polymorphisms of the GSTM1, GSTT1 and GSTP1 genes under both the dominant and recessive models. We also analyzed the relationship between combined genotypes and dysmenorrhea (Table 4) . We presumed that the PP or Pp genotypes of ESR1, null mutations of GSTM1, GSTT1, and GSTP1 Val/Val polymorphisms were putative highrisk alleles for dysmenorrhea based on the association of the individual genotypes with the risk of dysmenorrhea. 
Subjects carrying all presumptive low-risk genotypes were
DISCUSSION
In this study, the prevalence of dysmenorrhea was 85.1%.
This frequency was a little higher than that reported in Table 4 . Association between combined genotype subgroups and dysmenorrhea other Korean community-based studies [20, 22] . The findings in this study support the results of other studies indicating that dysmenorrhea is common among adolescents.
Only few studies have investigated genetic susceptibility to dysmenorrhea [7, 8, 23] , and most epidemiological studies did not include questions about family history in the questionnaires provided to subjects. We found a significant relationship between the first-degree family history and dysmenorrhea, suggesting a genetic predisposition toward dysmenorrhea. In addition, there was a significant association between ESR1 gene polymorphisms and dysmenorrhea. This relationship remained significant even after adjustment for PMS, years elapsed after menarche, and family history of dysmenorrhea (which showed significant associations with dysmenorrhea in participants using two-by-two c 2 analyses). It is unclear how the anonymous intronic polymorphism of the ESR1 gene influences protein function. However, tamoxifen, a selective estrogen-receptor modulator, was reported to exert a direct effect on uterine contractile activity, and this finding may explain the decrease in menstrual pain and cramps noted in the subjects with dysmenorrhea [24] . Several studies have shown that the PP genotype of the ESR1 gene is associated with subjects with a higher bone mineral density [25, 26] , a higher risk of premenopausal hysterectomy, and an earlier onset of menopause due to menorrhagia and fibroids [27] . These findings suggest that local estrogenic action is more potent in women carrying the PP genotype.
However, some studies have reported contradictory findings in which the PP genotype frequency was low in patients with endometriosis, a well-known estrogen-dependent disease [12, 28] . These opposite results may reflect the possibility that most of the subjects with dysmenorrhea in our study had primary dysmenorrhea rather than a secondary dysmenorrhea such as endometriosis. Therefore, we believe that primary dysmenorrhea may partially result from local estrogenic action, but that the detailed estrogen-mediated pathway involved in primary dysmenorrhea may be different from that in secondary dysmen- We did not observe any significant association between GST-related genes and dysmenorrhea. This is in contrast to another study in which it was reported that the GSTM1 genotype was associated with an increased risk of dysmenorrhea [23] . However, more recent studies have reported results similar to our findings, although these studies focused on the association of GST-related genes with endometriosis [9, 10, 31, 32] . Nevertheless, the possibility of a false-negative result due to the low statistical power of our analysis cannot be excluded, and further study with a larger sample size will be necessary. We also found no trend of increasing risk for dysmenorrhea in association with the number of putative GST-related and ESR1 highrisk genotypes in our analysis of the combined genotype subgroups.
This study is the first to investigate the relationship between ESR1 genotypes and dysmenorrhea in adolescents.
Another strength of this research is that the study subjects were all 16 to 17-yr-old adolescent female students, whereas the age ranges of subjects included in most other dysmenorrhea studies varied widely. The adolescent period is a transitional period, and the disease features of adolescents are very different from those of other age groups in the clinical field of obstetrics and gynecology [33] . A previous study showed that dysmenorrhea occurs most commonly among young women, and its prevalence tends to decrease after the age of 25 yr [34] . Therefore, the association of dysmenorrhea with many factors was well defined in our study. One limitation of this study is that we did not confirm the presence of organic diseases such as endometriosis since we did not perform an endometrium biopsy or pelvic ultrasonography. However, we excluded subjects who were diagnosed with or received treatment for obstetric/gynecological diseases as well as subjects who were suspected of having organic pelvic disease on the basis of their clinical characteristics. The second limitation of this study is the small number of subjects without dysmenorrhea, which was due to a higher prevalence of dysmenorrhea than expected. Although we used nonparametric statistical methods to analyze the association of dysmenorrhea with ESR1 gene polymorphisms, the positive association might be less precise due to the small number of subjects without dysmenorrhea.
In summary, our results suggest that ESR1 gene polymorphisms may be associated with a risk for dysmenorrhea. Further study using a larger population would be necessary to exclude the possibility of a causal relationship between the ESR1 genotype and dysmenorrhea. This further research will provide a better understanding of the pathogenesis of dysmenorrhea and estrogen-dependent uterine disease.
